<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="22/02/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1493333" creator="Yo Shidahara">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>1493333</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Protein_molecule" id="T1" lex="I_kappa_B/MAD-3">I kappa B/MAD-3</term> masks the <term sem="Protein_domain_or_region" id="A101">nuclear localization signal of <term sem="Protein_molecule" id="T2" lex="NF-kappa_B_p65">NF-kappa B p65</term></term> and requires the <term sem="Protein_domain_or_region" id="T3" lex="transactivation_domain">transactivation domain</term> to inhibit <term sem="Other" id="T4" lex="NF-kappa_B_p65_DNA_binding"><term sem="Protein_molecule" id="T5" lex="NF-kappa_B_p65">NF-kappa B p65</term> <term sem="DNA_domain_or_region" id="A1">DNA</term> binding</term>.</sentence>
<event id="E1">
<type class="Negative_regulation" />
<theme idref="A101" />
<cause idref="T1" />
<clue>I kappa B/MAD-3 <clueType>masks</clueType> the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.</clue>
<comment>TPS A101</comment>
</event>
<event id="E2">
<type class="Binding" />
<theme idref="T5" />
<theme idref="A1" />
<clue>I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA <clueType>binding</clueType>.</clue>
</event>
<event id="E3">
<type class="Negative_regulation" />
<theme idref="E2" />
<cause idref="T1" />
<clue>I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to <clueType>inhibit</clueType> NF-kappa B p65 DNA binding.</clue>
</event>
<event id="E101">
<type class="Correlation" />
<theme idref="E3" />
<theme idref="T3" />
<clue>I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and <clueType>requires</clueType> the transactivation domain <linkTheme>to</linkTheme> inhibit NF-kappa B p65 DNA binding.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The active nuclear form of the <term sem="Protein_complex" id="T6" lex="NF-kappa_B_transcription_factor_complex">NF-kappa B transcription factor complex</term> is composed of two <term sem="Protein_molecule" id="T7" lex="DNA_binding_subunit">DNA binding subunits</term>, <term sem="Protein_molecule" id="T8" lex="NF-kappa_B_p65">NF-kappa B p65</term> and <term sem="Protein_molecule" id="T9" lex="NF-kappa_B_p50">NF-kappa B p50</term>, both of which share extensive <term sem="Other" id="T10" lex="N-terminal_sequence_homology">N-terminal sequence homology</term> with the <term sem="Protein_molecule" id="T11" lex="v-rel_oncogene_product">v-rel oncogene product</term>.</sentence>
<event id="E4">
<type class="Binding" />
<theme idref="T7" />
<theme idref="T8" />
<clue>The active nuclear form of the NF-kappa B transcription factor complex is <clueType>composed</clueType> <linkTheme>of</linkTheme> two DNA binding subunits, NF-kappa B p65 and NF-kappa B p50, both of which share extensive N-terminal sequence homology with the v-rel oncogene product.</clue>
</event>
<sentence id="S3">The <term sem="Protein_molecule" id="T12" lex="NF-kappa_B_p65_subunit"><term sem="Protein_complex" id="T13" lex="NF-kappa_B_p65">NF-kappa B</term> p65 subunit</term> provides the <term sem="Other" id="T14" lex="transactivation_activity">transactivation activity</term> in this complex and serves as an intracellular receptor for a <term sem="Other" id="T15" lex="cytoplasmic_inhibitor">cytoplasmic inhibitor</term> of <term sem="Protein_complex" id="T16" lex="NF-kappa_B">NF-kappa B</term>, termed <term sem="Protein_molecule" id="A2">I kappa B</term>.</sentence>
<event id="E5">
<type class="Binding" />
<theme idref="T12" />
<theme idref="A2" />
<clue>The NF-kappa B p65 subunit provides the transactivation activity in this complex and <clueType>serves as</clueType> an intracellular <clueType>receptor</clueType> <linkTheme>for</linkTheme> a cytoplasmic inhibitor of NF-kappa B, termed I kappa B.</clue>
<comment>NER T13,T12, T16 MOD</comment>
</event>
<event id="E6">
<type class="Negative_regulation" />
<theme idref="T16" />
<cause idref="A2" />
<clue>The NF-kappa B p65 subunit provides the transactivation activity in this complex and serves as an intracellular receptor for a <clueLoc>cytoplasmic</clueLoc> <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> NF-kappa B, termed I kappa B.</clue>
</event>
<event id="E32">
<type class="Positive_regulation" />
<theme idref="E102" />
<cause idref="T12" />
<clue>The NF-kappa B p65 subunit <clueType>provides</clueType> the transactivation activity in this complex and serves as an intracellular receptor for a cytoplasmic inhibitor of NF-kappa B, termed I kappa B.</clue>
</event>
<event id="E102">
<type class="Positive_regulation" />
<cause idref="T16" />
<clue>The NF-kappa B p65 subunit provides the <clueType>transactivation activity</clueType> <linkCause>in</linkCause> <corefCause>this complex</corefCause> and serves as an intracellular receptor for a cytoplasmic inhibitor of NF-kappa B, termed I kappa B.</clue>
</event>
<sentence id="S4">In contrast, <term sem="Protein_molecule" id="T17" lex="NF-kappa_B_p50">NF-kappa B p50</term> alone fails to stimulate <term sem="Other" id="T18" lex="kappa_B-directed_transcription"><term sem="DNA_domain_or_region" id="A3">kappa B</term>-directed <term sem="Other" id="A4">transcription</term></term>, and based on prior in vitro studies, is not directly regulated by <term sem="Protein_molecule" id="T19" lex="I_kappa_B">I kappa B</term>.</sentence>
<event id="E7">
<type class="Regulation" />
<theme idref="A4" />
<cause idref="A3" />
<clue>In contrast, NF-kappa B p50 alone fails to stimulate kappa B-<clueType>directed</clueType> transcription, and based on prior in vitro studies, is not directly regulated by I kappa B.</clue>
</event>
<event assertion="non-exist" id="E8">
<type class="Positive_regulation" />
<theme idref="E7" />
<cause idref="T17" />
<clue>In contrast, NF-kappa B p50 alone fails to <clueType>stimulate</clueType> kappa B-directed transcription, and based on prior in vitro studies, is not directly regulated by I kappa B.</clue>
</event>
<event assertion="non-exist" id="E9">
<type class="Regulation" />
<theme idref="T17" />
<cause idref="T19" />
<clue>In contrast, NF-kappa B p50 alone fails to stimulate kappa B-directed transcription, and based on prior in vitro studies, is not directly <clueType>regulated</clueType> <linkCause>by</linkCause> I kappa B.</clue>
</event>
<sentence id="S5">To investigate the molecular basis for the critical regulatory interaction between <term sem="Protein_molecule" id="T20" lex="NF-kappa_B">NF-kappa B</term> and <term sem="Protein_molecule" id="T21" lex="I_kappa_B/MAD-3">I kappa B/MAD-3</term>, a series of <term sem="Protein_family_or_group" id="T22" lex="human_NF-kappa_B_p65_mutant">human <term sem="Protein_molecule" id="T23" lex="NF-kappa_B_p65">NF-kappa B p65</term> mutants</term> was identified that functionally segregated <term sem="Other" id="A5">DNA</term> binding, <term sem="Other" id="T24" lex="I_kappa_B-mediated_inhibition"><term sem="Protein_molecule" id="T25" lex="I_kappa_B">I kappa B</term>-mediated inhibition</term>, and <term sem="Other" id="T26" lex="I_kappa_B-induced_nuclear_exclusion"><term sem="Protein_molecule" id="T27" lex="I_kappa_B">I kappa B</term>-induced nuclear exclusion</term> of this <term sem="Protein_family_or_group" id="T28" lex="transcription_factor">transcription factor</term>.</sentence>
<event uncertainty="doubtful" id="E33">
<type class="Correlation" />
<theme idref="T20" />
<theme idref="T21" />
<clue>To investigate the molecular basis for the critical <clueType>regulatory interaction</clueType> <linkTheme>between</linkTheme> NF-kappa B and I kappa B/MAD-3, a series of human NF-kappa B p65 mutants was identified that functionally segregated DNA binding, I kappa B-mediated inhibition, and I kappa B-induced nuclear exclusion of this transcription factor.</clue>
</event>
<event id="E10">
<type class="Binding" />
<theme idref="T20" />
<theme idref="A5" />
<clue>To investigate the molecular basis for the critical regulatory interaction between NF-kappa B and I kappa B/MAD-3, a series of human NF-kappa B p65 mutants was identified that functionally segregated DNA <clueType>binding</clueType>, I kappa B-mediated inhibition, and I kappa B-induced nuclear exclusion <linkTheme>of</linkTheme> <corefTheme>this transcription factor</corefTheme>.</clue>
</event>
<event id="E11">
<type class="Negative_regulation" />
<theme idref="T20" />
<cause idref="T25" />
<clue>To investigate the molecular basis for the critical regulatory interaction between NF-kappa B and I kappa B/MAD-3, a series of human NF-kappa B p65 mutants was identified that functionally segregated DNA binding, I kappa B-<clueType>mediated inhibition</clueType>, and I kappa B-induced nuclear exclusion <linkTheme>of</linkTheme> <corefTheme>this transcription factor</corefTheme>.</clue>
</event>
<event id="E12">
<type class="Localization" />
<theme idref="T20" />
<clue>To investigate the molecular basis for the critical regulatory interaction between NF-kappa B and I kappa B/MAD-3, a series of human NF-kappa B p65 mutants was identified that functionally segregated DNA binding, I kappa B-mediated inhibition, and I kappa B-induced <clueLoc>nuclear</clueLoc> <clueType>exclusion</clueType> <linkTheme>of</linkTheme> <corefTheme>this transcription factor</corefTheme>.</clue>
</event>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="E12" />
<cause idref="T27" />
<clue>To investigate the molecular basis for the critical regulatory interaction between NF-kappa B and I kappa B/MAD-3, a series of human NF-kappa B p65 mutants was identified that functionally segregated DNA binding, I kappa B-mediated inhibition, and I kappa B-<clueType>induced</clueType> nuclear exclusion <linkTheme>of</linkTheme> <corefTheme>this transcription factor</corefTheme>.</clue>
</event>
<sentence id="S6">Results from in vivo expression studies performed with these <term sem="Protein_family_or_group" id="T29" lex="NF-kappa_B_p65_mutant">NF-kappa B p65 mutants</term> revealed the following: 1) <term sem="Protein_molecule" id="T30" lex="I_kappa_B/MAD-3">I kappa B/MAD-3</term> completely inhibits <term sem="Other" id="T31" lex="NF-kappa_B_p65-dependent_transcriptional_activation"><term sem="Protein_molecule" id="T32" lex="NF-kappa_B_p65">NF-kappa B p65</term>-dependent <term sem="Other" id="A7">transcriptional activation</term></term> mediated through the <term sem="DNA_domain_or_region" id="T33" lex="human_immunodeficiency_virus_type_1_kappa_B_enhancer"><term sem="Virus" id="T34" lex="human_immunodeficiency_virus_type_1">human immunodeficiency virus type 1</term> <term sem="DNA_domain_or_region" id="A6">kappa B enhancer</term></term> in <term sem="Cell_natural" id="T35" lex="human_T_lymphocyte">human T lymphocytes</term>, 2) the binding of <term sem="Protein_molecule" id="T36" lex="I_kappa_B/MAD-3">I kappa B/MAD-3</term> to <term sem="Protein_molecule" id="T37" lex="NF-kappa_B_p65">NF-kappa B p65</term> is sufficient to retarget <term sem="Protein_molecule" id="T38" lex="NF-kappa_B_p65">NF-kappa B p65</term> from the <term sem="Cell_component" id="T39" lex="nucleus">nucleus</term> to the <term sem="Cell_component" id="T40" lex="cytoplasm">cytoplasm</term>, 3) selective deletion of the functional <term sem="Protein_domain_or_region" id="A8">nuclear localization signal</term> present in the <term sem="Protein_domain_or_region" id="T41" lex="Rel_homology_domain">Rel homology domain</term> of <term sem="Protein_molecule" id="T42" lex="NF-kappa_B_p65">NF-kappa B p65</term> disrupts its ability to engage <term sem="Protein_molecule" id="T43" lex="I_kappa_B/MAD-3">I kappa B/MAD-3</term>, and 4) the unique <term sem="Protein_domain_or_region" id="T44" lex="C-terminus">C-terminus</term> of <term sem="Protein_molecule" id="T45" lex="NF-kappa_B_p65">NF-kappa B p65</term> attenuates its own nuclear localization and contains sequences that are required for <term sem="Other" id="T46" lex="I_kappa_B-mediated_inhibition"><term sem="Protein_molecule" id="T47" lex="I_kappa_B">I kappa B</term>-mediated inhibition</term> of <term sem="Other" id="T48" lex="NF-kappa_B_p65_DNA_binding_activity"><term sem="Protein_molecule" id="T49" lex="NF-kappa_B_p65">NF-kappa B p65</term> <term sem="Other" id="A9">DNA</term> binding activity</term>.</sentence>
<event id="E14">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="A6" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation <clueType>mediated</clueType> <linkCause>through</linkCause> the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="A7" />
<cause idref="T32" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-<clueType>dependent</clueType> transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E16">
<type class="Negative_regulation" />
<theme idref="E15" />
<cause idref="T30" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely <clueType>inhibits</clueType> NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer <clueLoc>in human T lymphocytes</clueLoc>, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E17">
<type class="Binding" />
<theme idref="T36" />
<theme idref="T37" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the <clueType>binding</clueType> <linkTheme>of</linkTheme> I kappa B/MAD-3 <linkTheme>to</linkTheme> NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E18">
<type class="Localization" />
<theme idref="T38" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to <clueType>retarget</clueType> NF-kappa B p65 <clueLoc>from the nucleus to the cytoplasm</clueLoc>, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E118">
<type class="Positive_regulation" />
<theme idref="E18" />
<cause idref="E17" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is <clueType>sufficient</clueType> <linkTheme>to</linkTheme> retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E19">
<type class="Negative_regulation" />
<theme idref="A8" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective <clueType>deletion</clueType> <linkTheme>of</linkTheme> the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E20">
<type class="Binding" />
<theme idref="T42" />
<theme idref="T43" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts <corefTheme>its</corefTheme> ability to <clueType>engage</clueType> I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E21">
<type class="Negative_regulation" />
<theme idref="E20" />
<cause idref="E19" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 <clueType>disrupts</clueType> its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E22">
<type class="Localization" />
<theme idref="T45" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates <corefTheme>its</corefTheme> own <clueLoc>nuclear</clueLoc> <clueType>localization</clueType> and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E23">
<type class="Negative_regulation" />
<theme idref="E22" />
<cause idref="T44" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 <clueType>attenuates</clueType> its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E24">
<type class="Binding" />
<theme idref="A9" />
<theme idref="T49" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA <clueType>binding</clueType> activity.</clue>
</event>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="T47" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-<linkCause>mediated</linkCause> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B p65 DNA binding activity.</clue>
</event>
<event id="E26">
<type class="Correlation" />
<theme idref="T44" />
<theme idref="E25" />
<clue>Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and <clueType>contains sequences</clueType> that are <clueType>required</clueType> <linkTheme>for</linkTheme> I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.</clue>
</event>
<sentence id="S7">Together, these findings suggest that the <term sem="Protein_domain_or_region" id="A10">nuclear localization signal</term> and <term sem="Protein_domain_or_region" id="T50" lex="transactivation_domain">transactivation domain</term> of <term sem="Protein_molecule" id="T51" lex="NF-kappa_B_p65">NF-kappa B p65</term> constitute a bipartite system that is critically involved in the inhibitory function of <term sem="Protein_molecule" id="T52" lex="I_kappa_B/MAD-3">I kappa B/MAD-3</term>.</sentence>
<event id="E27">
<type class="Negative_regulation" />
<cause idref="T52" />
<clue>Together, these findings suggest that the nuclear localization signal and transactivation domain of NF-kappa B p65 constitute a bipartite system that is critically involved in the <clueType>inhibitory function</clueType> <linkCause>of</linkCause> I kappa B/MAD-3.</clue>
</event>
<event uncertainty="probable" id="E28">
<type class="Correlation" />
<theme idref="A10" />
<theme idref="T50" />
<theme idref="E27" />
<clue>Together, these findings suggest that the nuclear localization signal and transactivation domain of NF-kappa B p65 <clueType>constitute</clueType> a bipartite <clueType>system</clueType> that is critically <clueType>involved</clueType> <linkTheme>in</linkTheme> the inhibitory function of I kappa B/MAD-3.</clue>
</event>
<sentence id="S8">Unexpectedly, our in vivo studies also demonstrate that <term sem="Protein_molecule" id="T53" lex="I_kappa_B/MAD-3">I kappa B/MAD-3</term> binds directly to <term sem="Protein_molecule" id="T54" lex="NF-kappa_B_p50">NF-kappa B p50</term>.</sentence>
<event id="E29">
<type class="Binding" />
<theme idref="T53" />
<theme idref="T54" />
<clue>Unexpectedly, our in vivo studies also demonstrate that I kappa B/MAD-3 <clueType>binds</clueType> directly <linkTheme>to</linkTheme> NF-kappa B p50.</clue>
</event>
<sentence id="S9">This interaction is functional as it leads to retargeting of <term sem="Protein_molecule" id="T55" lex="NF-kappa_B_p50">NF-kappa B p50</term> from the <term sem="Cell_component" id="T56" lex="nucleus">nucleus</term> to the <term sem="Cell_component" id="T57" lex="cytoplasm">cytoplasm</term>.</sentence>
<event id="E30">
<type class="Localization" />
<theme idref="T55" />
<clue>This interaction is functional as it leads to <clueType>retargeting</clueType> <linkTheme>of</linkTheme> NF-kappa B p50 <clueLoc>from the nucleus to the cytoplasm</clueLoc>.</clue>
</event>
<event id="E31">
<type class="Positive_regulation" />
<theme idref="E30" />
<cause idref="E29" />
<clue><corefCause idref1="E29">This interaction</corefCause> is functional as <corefCause idref1="E29">it</corefCause> <clueType>leads</clueType> <linkTheme>to</linkTheme> retargeting of NF-kappa B p50 from the nucleus to the cytoplasm.</clue>
<comment>corefCause=multilayer</comment>
</event>
<sentence id="S10">However, no loss of <term sem="Other" id="T58" lex="DNA_binding_activity"><term sem="DNA_domain_or_region" id="A11">DNA</term> binding activity</term> is observed, presumably reflecting the unique <term sem="Protein_domain_or_region" id="T59" lex="C-terminal_domain">C-terminal domain</term> that is distinct from that present in <term sem="Protein_molecule" id="T60" lex="NF-kappa_B_p65">NF-kappa B p65</term>.</sentence>
<event id="E34">
<type class="Binding" />
<theme idref="T60" />
<theme idref="A11" />
<clue>However, no loss of DNA <clueType>binding activity</clueType> is observed, presumably reflecting the unique C-terminal domain that is distinct from that present in NF-kappa B p65.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event assertion="non-exist" id="E35">
<type class="Negative_regulation" />
<theme idref="E34" />
<cause idref="E29" />
<clue>However, <clueType>no loss</clueType> <linkTheme>of</linkTheme> DNA binding activity is <clueType>observed</clueType>, presumably reflecting the unique C-terminal domain that is distinct from that present in NF-kappa B p65.</clue>
<comment>No corefCause</comment>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
